Wikipedia -WSS

Wikipedia

author：leisure time 2025-09-28 02:32:22 - browse：14

Monica Bertagnolli -- Health Policy coverage from STAT — Dr. Monica Bertagnolli speaks during a visit from first lady Jill Biden to the University of California San Francisco Helen Diller Family Comprehensive Cancer Center in San Francisco, Friday, Oct. 7, 2022. (AP Photo/Jeff Chiu, Pool) Jeff Chiu/AP

WASHINGTON — Sen. Bernie Sanders (I-Vt.) will hold a confirmation hearing next month for Monica Bertagnolli, President Biden’s nominee to run the National Institutes of Health, he said Friday.

Sanders, whose health committee oversees the confirmation of the NIH nominee, had refused to hold a hearing on Bertagnolli until the Biden administration promised more drug pricing reform.

Newsletters

Sign up for D.C. Diagnosis

An insider's guide to the politics and policies of health care.

Please enter a valid email address. Privacy Policy

HHS announced Friday a deal with Regeneron on the development of the Covid-19 monoclonal antibody. That deal seems to have satisfied Sanders’ demands, though Sanders said the administration must add reasonable pricing provisions to all drugs developed with the help of government funding.

“I welcome the Biden Administration’s announcement today that if Regeneron, through a $326 million contract recently signed with HHS, successfully develops a next generation monoclonal antibody for Covid-19 prevention, the list price of this drug must be equal to or lower than the price in other major countries,” Sanders said in a release.

Sen. Elizabeth Warren (D-Mass.) also had withheld support for Bertagnolli’s nomination until Bertagnolli agreed to Warren’s ethics demands. Bertagnolli agreed to not join the pharmaceutical industry or accept payment from the drug industry, until at least four years after leaving her government position.

Previous article： How to save PrEP access — and even expand it
Next article： Stem cell biologist probes earliest stages of human development

WSS

Depression: FDA OKs Otsuka Pharmaceuticals digital therapeutic

Trial using CRISPR to edit HIV out of cells disappoints

Ancient Greek ideas underpin modern concepts of pregnancy

Scientists uncover potential path to treating deadly childhood tumor

Trial using CRISPR to edit HIV out of cells disappoints

Bird flu in dairy cattle: New measures to control spread to humans

hotspot

Wikipedia

Sign up for D.C. Diagnosis

focus

Walensky prepares to leave CDC — and Congress — behind

First over

Cancer drug shortages should be causing more outrage

U.K. decision on ALS drug has neurologists, advocates up in arms

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Harvard scientists, with Google, unveil the most detailed brain map ever

After affirmative action ruling, medical educators look to 'holistic review'

IVF doctors demand details after CooperSurgical lawsuit

Peter Hotez and the public health issue of online harassment

The untold story of TV’s first prescription drug ad

explore

Drug companies' payments and gifts affect physicians' prescribing

Immune cells and nerve overgrowth may explain recurring UTI pain

U.K. decision on ALS drug has neurologists, advocates up in arms

Pregnant women don't need prenatal multivitamins, study concludes

Change Healthcare cyberattack affects 25% of CVS/Aetna insurance claims

Ozempic has benefits for kidney disease as well as diabetes

entertainment

hotspot

knowledge

entertainment